Navigation Links
HealthCarePoint and ViS Research Streamline Sharing of Qualifications by Medical Researchers

Austin, TX (PRWEB) July 30, 2013

HealthCarePoint (HCP) and ViS Research today announced they will connect platforms to improve cost-efficiency in clinical research. The partnership will allow clinical trial planners to quickly access clinical research professionals’ Personal Experience and Training (PET) records through the ViS platform and give clinical research sites access to human resource management systems hosted by HealthCarePoint at no cost.

Sites and clinical researchers benefit from an efficient way to share their qualifications, while trial planners gain ready access to structured data for compliance and site evaluation for inclusion in trials. The number of healthcare professionals that are already holding their qualification records through HealthCarePoint's network is close to 500,000, so it is clear that the impact will be substantial.

Users of ViS' online feasibility platform, which include most large pharma companies and CROs, will have seamless and quick access to the information they need for site feasibility assessment. The functional integration of these two innovative technologies will provide a complete solution to industry sponsors, CROs, IRB representatives, and research associations who need to search, find, retrieve and maintain verifiable information on professional competencies for regulatory compliance purposes.

The collaboration aims to revamp an outdated process, which is still based on questionnaires and numerous silos of stale information. On the one hand, it eliminates the need for the cumbersome feasibility questionnaires. On the other, it allows professionals to share their portable PET records, across the industry. The end result is that the time spent conducting feasibility assessment and building records drops to hours, instead of months, and researchers save billions per year in time and resources.

“HealthcarePoint’s and ViS’ patent-pending technologies are complementary and have been proven to be a catalyst for cost-efficiency in this industry,” says Al O.Pacino, HealthCarePoint President. "Empowering researchers to exchange and dynamically share information in real time through permission-based networks will improve efficiency, compliance and competitiveness. The rapid adoption we are seeing indicates that our industry is ready to move beyond ‘silo’ models and into global collaborative environments".

"Society wins when medical researchers focus less on paperwork and more on patients," says Fabio Thiers, MD, PhD, ViS Research CEO. “This collaboration revamps the site feasibility assessment process. Trial planners have had to resort to creating burdensome questionnaires for researchers, because they do not have an efficient way to access and make sense of the information about locations, sites and investigators. Now they have a better option".

About Corporation is a private organization focused on creating and establishing professional user-based tools and business-to-business networking technologies. Members use our cutting-edge networking technologies to streamline business and compliance processes by connecting organizations, their employees and contractors through a series of shareable, VIP Opt-In collaborative networks seamlessly integrated to perform daily tasks and activities, and exchange and update information in real time globally. Members also use our leverage to save time and financial resources on millions of products, services and specialties used in the everyday supply/service chain management of healthcare and clinical research.

For more information on how you can become involved, please visit, e-mail info(at)HealthCarePoint(dot)com or call 512-302-3113.

About ViS Research
ViS Research (ViS) is an analytics company whose online site feasibility platform transforms how locations, sites and investigators are evaluated for inclusion in clinical trials. The ViS platform enables the more than 400,000 disease-specific research sites and 240,000 investigators worldwide to efficiently display their capabilities, while providing multi-dimensional analytics about the locations where the sites operate. All the analytics are made easily accessible through interactive visualizations and user-friendly search tools, which answer trial planning questions at a small fraction of the time spent and cost incurred through conventional methods. Trial planners can quickly reach decisions and directly engage with the sites, through efficient collaboration networks.

The ViS Research Institute was created as a global enterprise in 2010. Its interdisciplinary team interconnects traditional and emerging markets through regional hubs in New York City, São Paulo, Mumbai, and Frankfurt am Main. More information at

Media contact for HealthCarePoint: Al O. Pacino II, President:     Info(at)HealthCarePoint(dot)com, +1 512-302-3113
Media contact for ViS: James Rosenstein, Head of Global Communications: james.rosenstein(at)visresearch(dot)com, +1 917 715 2820

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. HealthCarePoint Pledges More Than $10 Million in Software and Technology Services to Help Support ACRES Global Network for Clinical Research
2. Global Markets for Rapid Medical Diagnostic Kits (Mdks) to Surpass $24.2 Billion by 2017: BCC Research
3. Poland Health Insurance Market Analysis and 2015 Forecasts in New Research Report at
4. China Poultry Vaccine Industry Analysis in New Market Research Report at
5. Beaumont Health System Launches Research Trial of Bioresorbable Heart Scaffold
6. Parents dont fully understand biobank research, study finds
7. Researchers identify genetic mutation linked to congenital heart disease
8. Beaumont Health System launches research trial of bioresorbable heart scaffold
9. Global Terahertz Radiation Systems Market – THz 2018 Analysis and Forecast in Research Report at
10. Leading Global Clinical Research Organization chooses GBS to Support their IBM Domino Infrastructure
11. Laser Processing Market to Grow at a 9.71% CAGR by 2018 Forecasts in New Research Report at
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... For the millions of people ... Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic intermittent catheter. “Hollister ... free catheter portfolio,” said Michael Gresavage, Vice President North America. "We designed our ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... December 01, 2015 , ... With FCPX Overlay: Grit ... full control over customization, the possibilities are truly endless, all with a click of ... depth position, vertical flip, horizontal flip, depth of field and more, all within Final ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... engine optimization companies, announced today that it has officially launched a sleek, mobile-ready ... SEO, explained that his company’s new website clearly outlines the benefits that its ...
(Date:11/30/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... a 2015-2016 inductee into its VIP Woman of the Year Circle. She is recognized ... nation’s leading networking organization exclusively for professional women, boasting more than 850,000 members and ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... SAN FRANCISCO , Dec. 1, 2015  InCarda ... the development and commercialization of therapies for cardiovascular conditions ... established a subsidiary business in Australia ... clinical trial in Australia in ... with leading investigators and medical centers in ...
(Date:12/1/2015)... and TELTOW, Germany , December ... (SMI) , a leading global manufacturer of eye and ... has included SMI remote eye trackers as a ... healthcare providers assess concussions, eye sight, and medical and ... -oem technology is part of SMI,s mass-market-ready eye tracking ...
(Date:12/1/2015)... -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced ... 2016 as the ex-distribution date for Ampio,s previously announced ... Stock of Aytu BioScience, Inc. As announced, Ampio will ... every five (5) shares of Ampio Common Stock owned ... date will be January 4, 2016. ...
Breaking Medicine Technology: